πŸ‡ΊπŸ‡Έ

US SEC Filing Intelligence

Β· daily

Contract Deobligations Alert β€” October 09, 2026

The digest covers 30 federal contract records totaling $1,703,692,365 in aggregate obligation, all classified as civilian with zero defense-related awards. The mix is dominated by Department of Veterans Affairs construction and health-insurance orders, Department of Agriculture Forest Service airtanker and fire-aviation delivery orders, and Homeland Security IT and border-security work. The highest-materiality record is TriWest Healthcare Alliance's $900,485,186 VA delivery order, though its one-month performance window and $0 outlayed make the headline value an unreliable indicator of realized revenue. Nearly every record carries a neutral signal (average strength 3.2/10), so conviction is low across the set. The principal watch item is the gap between obligated and outlayed values, which ranges from $0 to roughly 84% spent, and the ambiguity around award-date versus performance-period sequencing in several records.

30 total filings
Β· daily

Contract Option Exercises β€” October 09, 2026

This digest covers 50 contract option exercise records dated October 9, 2026, aggregating $1,935,265,219 in total obligation with zero defense-related awards, so the entire stream is civilian (VA, HHS, DHS, USDA, GSA, NASA, Treasury, Education, PBGC). The dominant themes are VA facilities construction and staffing (many SDVOSB set-asides such as Valiant Construction, Briston Construction, and RBVETCO), USDA Forest Service wildfire aviation (Neptune Aviation, AERO AIR, Helicopter Transport Services, ROTAK, Billings Flying Service), and DHS/CBP and USCIS IT and cybersecurity services (Accenture Federal, SALIENT CRGT, Spatial Front, Definitive Logic). The highest-materiality award is TriWest Healthcare Alliance's $900,485,186 VA delivery order, but its single-month performance period and $0 outlays make it a poor proxy for recurring revenue. Average signal strength is only 3.1/10 and every contract is classified neutral, so conviction is low across the stream; the principal watch item is the large gap between obligated and ceiling values (e.g., Accenture Federal's $14.8M obligation against a $121.4M ceiling), which depends on option exercise that is not yet committed.

50 total filings
Β· daily

Federal Professional Services Contracts β€” October 09, 2026

Three federal professional services contracts totaling $104,013,229 in obligations were reviewed for the period October 9, 2026, with none defense-related (0 of 3) and all carrying neutral signals (average strength 2.7/10). The civilian mix is split across NASA (two awards totaling $86,854,494 in obligations, from AMERESCO SELECT, INC. at $48,129,004 and SOUTHWEST RESEARCH INSTITUTE at $38,725,490) and GSA (Deloitte Consulting LLP at $17,158,734). The dominant theme is long-duration civilian facilities-energy and space R&D spending, with NASA contracts running to 2029 and 2036 respectively. The highest-materiality award is AMERESCO SELECT's firm-fixed-price Wallops Island energy retrofit, though its public-equity relevance is not established in the data. The key watch item is that Deloitte's award has $0 outlayed and only about 9.7% of its $176,034,150 ceiling obligated, so near-term revenue recognition remains unproven.

3 total filings
Β· daily

Federal IT & Cybersecurity Contracts β€” October 09, 2026

The 11 federal IT and cybersecurity awards dated 2022 through 2026 aggregate $231,292,955 in total obligation, with 0 of 11 defense-related and all 11 civilian (DHS, HHS, GSA, Treasury, VA). The dominant theme is DHS, which accounts for five awards (Anduril $42,066,939; SALIENT CRGT $23,895,601; DEFINITIVE LOGIC $16,499,505; Accenture Federal $14,823,471; SPATIAL FRONT $10,831,013), followed by HHS/CMS with three. The highest-conviction signal is Accenture Federal Services' CBP Cyber Security Operations Center delivery order ($14,823,471 obligated against a $121,415,324 ceiling), a large-prime cybersecurity win under full and open competition, though it has $0 outlayed so far. The most material risk is execution and conversion: Booz Allen Hamilton's GSA order ($38,452,810 obligated, $0 outlayed against a $373,036,880 ceiling) and Spatial Front's USCIS order (only $1,347,491 of $10,831,013 outlayed) show large headline values with little realized revenue. Several records lack public-company linkage, tickers, or financials, so direct equity impact is not established for most entities.

11 total filings
Β· daily

NASA & Space Contracts Intelligence β€” October 09, 2026

This digest covers a single NASA & Space Contracts Intelligence record from October 09, 2026, representing $12,413,999 in total obligation, all civilian and none defense-related (0/1 defense). The sole award is a non-competed cost-plus-fixed-fee delivery order from NASA Management Office - JPL to California Institute of Technology, a nonprofit university rather than a publicly traded company. Only about 17% ($2,114,426) of the current obligation has been outlayed against a $22,615,533 base-plus-options value running through 2028-09-30. The highest-conviction read is neutral: the award confirms an ongoing government-funded space R&D relationship but offers no direct equity exposure or budget-trend evidence. The key watch item is whether option exercises or modifications lift obligated value toward the full $22,615,533 ceiling, roughly $10.2 million of which currently depends on future government action.

1 total filings
Β· daily

All HHS Contracts β€” October 09, 2026

The 8 HHS contracts in this period carry a combined obligation of $198,613,842 with zero defense-related awards, so the entire set is civilian, spread across BARDA/ASPR (Abbott Laboratories, Basilea Pharmaceutica), CDC (CAS FSE JV II, NTT DATA, ATL International), and CMS (RELI Group, VERSA Integrated Solutions, eMagine IT). The dominant theme is health IT and facilities/application services sustainment rather than new platform spend, with CMS accounting for the bulk of the IT-services awards. The highest-materiality signal is Abbott Laboratories' $65,469,510 firm-fixed-price BARDA award for clinical validation of its TBI diagnostic, though it is R&D funding with only about $17.6M outlayed and no confirmed FDA decision. The average signal strength is 3.4/10 and every contract is classified neutral, so no contract supports a directional thesis on its own. The key watch item is Basilea Pharmaceutica's $45.2M obligation against a $191.9M ceiling, where option exercise would be the main driver of value, and the recipient's public-market exposure cannot be determined from the data.

8 total filings
Β· daily

Mega Contracts Monitor ($100M+) β€” October 09, 2026

This digest covers a single Mega Contracts Monitor ($100M+) record dated October 7-9, 2026, carrying a total obligation of $900,485,186, all civilian and none defense-related (0/1 defense count). The sole award is a Department of Veterans Affairs delivery order to TriWest Healthcare Alliance Corp, a Phoenix, AZ-based U.S.-owned firm, under a firm fixed-price structure awarded via full and open competition with no set-aside. The dominant theme is VA health insurance program administration (NAICS 524114, PSC G007), but the signal is weak: the performance period is only one month (2026-09-01 to 2026-09-30), outlays to date are $0, and the description suggests a periodic 'EXPRESS REPORT: FY26 SEPTEMBER' order rather than a multi-year program. The highest-conviction takeaway is that the headline value should not be read as realized revenue; the key watch item is whether the award date (2026-10-07) falling after the performance period signals a data or timing anomaly and whether similar orders recur.

1 total filings
Β· daily

High-Value Federal Grants ($5M+) β€” October 09, 2026

The 30 high-value federal grant and contract awards in this stream total $1,703,692,365 in obligations, with zero defense-related awards; all 30 are civilian (VA, HHS/BARDA, DHS, USDA Forest Service, NASA, GSA, Treasury, CDC and others). The dominant theme is Department of Veterans Affairs facilities and healthcare spending, led by TriWest Healthcare Alliance's $900,485,186 single-month delivery order, which is the largest single obligation but carries $0 outlays and a period-of-performance/award-date mismatch that makes its recurring value unverifiable. The highest-conviction signal is the steady USDA Forest Service aviation program, where multiple small-business and large-recipient airtanker and helicopter delivery orders (Neptune Aviation, Aero Air, Helicopter Transport Services, ROTAK, Billings Flying Service) show consistent multi-year wildfire demand, though most recipients are private. The key watch item is execution: most awards show low outlay ratios or $0 outlays, so obligated value should not be treated as realized revenue until invoicing data appears.

30 total filings
Β· daily

General Federal Contracts β€” October 09, 2026

The 51 contracts in this October 9, 2026 digest aggregate $1,944,020,447 in total obligation, but the figure is dominated by a single $900,485,186 TriWest Healthcare Alliance VA delivery order that carries $0 outlayed and no visible recurrence, so headline value overstates durable revenue. None of the 51 awards are defense-related; the stream is entirely civilian, concentrated in VA facilities and construction (roughly a dozen awards), USDA Forest Service wildfire aviation (Neptune Aviation, Billings Flying Service, Helicopter Transport Services, ROTAK, HELI-1, AERO AIR), and DHS/CBP/USCIS IT and facilities work (Accenture Federal, Salient CRGT, Anduril, Spatial Front). The highest-materiality contract with actual execution evidence is the Accenture Federal CBP cybersecurity delivery order ($14,823,471 obligated against a $121,415,324 ceiling), while the largest outlay-backed awards are Neptune Aviation's airtanker orders (about 82-83% outlayed). Average signal strength is 3.1/10 and every contract is classified neutral, so the digest offers no directional call; the key watch item is whether the TriWest order and the 2026-era VA construction awards convert to outlays on schedule.

51 total filings
Β· daily

All NASA Contracts β€” October 09, 2026

Three NASA contracts totaling $99,268,494 in obligations were awarded or active in the period, with zero defense-related awards, making this a purely civilian space and facilities-energy snapshot. The largest is AMERESCO SELECT, INC.'s $48,129,004 firm-fixed-price energy-conservation delivery order at NASA Goddard (Wallops Island, VA), followed by SOUTHWEST RESEARCH INSTITUTE's $38,725,490 cost-plus-fixed-fee JUICE ultraviolet spectrograph work at NASA Marshall and California Institute of Technology's $12,413,999 cost-plus-fixed-fee delivery order from NASA JPL. The dominant theme is sustained NASA science and facilities spending, but the data does not establish agency budget trends. The highest-conviction read is the AMERESCO award's long-dated firm-fixed-price structure, though its parent's public-equity status is unverified. The key watch item is outlay progression: only about 42%, 16% and 17% of the respective obligations have been disbursed, so most value remains contingent on future funding and option actions.

3 total filings
Β· daily

S&P 500 Technology Sector SEC Filings β€” October 09, 2026

Across the 10 newly reviewed S&P 500 technology filings for 2026-10-09, the dominant theme is heavy insider selling by senior executives, concentrated among software, networking, and semiconductor names: Arista's CEO disposed of roughly $15M plus two smaller tranches, Analog Devices' Chief Operations/Tech Officer sold about $2.2M across two transactions, Datadog's CTO sold about $5.05M after option exercises, and Accenture's COO sold about $264K. Most of these sales were executed under Rule 10b5-1 plans, which dampens the signal value of any single transaction, though the clustering across companies in a single session is worth monitoring. The one substantive financial filing is Micron's 10-K for the fiscal year ended September 3, 2026, which reports revenue of $133,188M versus $37,378M in FY2025 (up 256%), net income of $84,969M versus $8,539M, gross margin expanding to 81% from 40%, and operating cash flow of $89,675M versus $17,525M. Micron's effective tax rate rose to 14.8% from 11.6% and interest expense fell to $106M from $477M after several debt tranches were repaid, while management supported an increase in authorized share repurchases. Gifting activity at Palo Alto Networks and NVIDIA and a board appointment at Cisco are governance items with limited direct market impact. The Micron filing is the materiality outlier, and the insider-selling cluster is the main sentiment counterweight.

10 high priority 10 total filings
Β· daily

Nasdaq 100 Stocks SEC Filings β€” October 09, 2026

The 2026-10-09 NASDAQ-100 SEC filing stream is dominated by one standout fundamental report: Micron Technology's FY2026 10-K, which shows revenue of $133,188M (up 256% from $37,378M), net income of $84,969M versus $8,539M, gross margin expanding to 81% from 40%, and operating cash flow of $89,675M, supporting a larger buyback authorization. Balance sheet deleveraging is evident, with senior note repayments through 2026 and interest expense down to $106M from $477M, though the effective tax rate rose to 14.8% from 11.6%. The remaining filings are governance and insider-activity items: Cisco added independent director Girish Rishi (committee assignments pending), NVIDIA's director made a 500,000-share gift under a 10b5-1 plan, and Analog Devices' COO/CTO Vivek Jain sold roughly $2.2M of stock across two transactions. Strategy Inc's DEFA14A is an incomplete excerpt with no substantive content and is excluded from quantitative analysis. Portfolio-level, the signal set is semiconductor-heavy and points to strong AI-cycle earnings power alongside modest, largely routine insider selling.

4 high priority 1 medium 5 total filings
Β· daily

US Activist Hedge Fund Institutional SEC 13D 13G β€” October 09, 2026

This digest covers 50 Schedule 13D/13G and amendment filings for the 'Activist & Institutional Activity' stream, all dated 2026-10-09 with event dates clustered around September 30 and October 2026. The population is dominated by passive institutional disclosures under Rule 13d-1(b) and 13d-1(c): Wasatch Advisors LP alone appears in roughly 17 filings, and Calamos, Sachem Head, Glazer Capital and Frazier entities each contribute several more. Only a small number of filings reflect genuine control or activist intent, most notably Omnitek Engineering (Hard Rock Holdco, 85.2% reported beneficial ownership and a control purpose), Melco Resorts (Melco group at 62.6% with delisting/deregistration under evaluation), Gogoro (Gold Sino and Mr. Yin acquiring new shares at US$2.48 with closing by October 13, 2026), and Nexpu/Top KingWin (CEO at 90.71% voting power through Class B shares). The enriched period-over-period fields are largely absent in these filings: most report ownership percentages and voting-power splits rather than revenue, margin or guidance trends, so quantitative trend synthesis is limited and I have not manufactured comparisons. The clearest signals are concentrated control, insider-driven share accumulation, and a set of exits or reductions (Sotera Health full exit by Sachem Head; INVO Fertility reduction from 40,000 to 35,000 shares). Several filings are of low relevance to an activist or major-shareholder focus (routine passive holdings in closed-end funds, ETFs and SPAC warrants) and are treated with low materiality.

9 high priority 41 medium 50 total filings
Β· daily

S&P 500 Financials Sector SEC Filings β€” October 09, 2026

The stream covers three SEC filings dated 2026-10-09, but only two fall within the S&P 500 Financials scope: AFLAC Inc. and Robinhood Ventures Fund I, both reporting Form 4 insider sales by 10% owners. Both sets of sales were executed under Rule 10b5-1 plans, which reduces their informational weight as signals of management conviction. AFLAC's 10% holder Japan Post Holdings sold roughly $1.35M at $112.80 plus a small $4.54K tranche, leaving it with 50.38M shares, so the disposal is modest relative to its stake. Robinhood Markets sold about $353K across two tranches in Robinhood Ventures Fund I, leaving 12.96M shares. The third filing, a Morgan Stanley Capital I Trust 2016-UBS11 Form 15, is an asset-backed trust termination and is outside the S&P 500 Financials constituent list. Period-over-period comparisons and forward-looking guidance were not present in the enriched data for these filings, so no quantitative YoY/QoQ trend or catalyst can be drawn. The dominant theme is 10b5-1 monetization by large holders, with no evidence of broader sector stress or guidance revisions in this batch.

3 high priority 3 total filings
Β· daily

S&P 500 Consumer Staples Sector SEC Filings β€” October 09, 2026

This Consumer Staples stream covers only two newly published filings for the 2026-10-09 window: a Hershey Form 4 showing continued 10b5-1 selling by the Hershey Trust, and an Altria 8-K extending its $3.0 billion revolving credit facility. Neither filing carries the period-over-period financial comparisons, guidance, or margin data the enriched schema promises, so portfolio-level trend analysis is not possible from this batch. The Hershey activity is the more market-relevant item: a 10% holder trust sold roughly 8,075 shares at about $162.42 (~$1.31M) across seven transactions, reducing its position to 616,119 shares, though the sales are pre-planned and the trust's selling is a structural diversification pattern rather than a directional call. The Altria amendment is administrative, pushing maturity from October 2029 to October 2030 with unchanged terms, signaling continued access to committed liquidity rather than any stress. Overall the batch offers limited actionable signal, and investors should treat the Hershey sales as a sentiment marker rather than a thesis change.

2 high priority 2 total filings
Β· daily

S&P 500 Industrials Sector SEC Filings β€” October 09, 2026

Six filings were reviewed for the USA S&P 500 Industrials stream; all six fall within scope. Delta Air Lines dominates the period: its September quarter 10-Q and 8-K show revenue growth of 21% YoY (GAAP) but operating margin compression to 7.2% from 10.1%, net income down 46.6%, and adjusted EPS of $1.72 flat YoY, as fuel prices rose 60% YoY to $3.61 per gallon and non-fuel unit costs rose 7.3%. Management guided Q4 2026 EPS to $1.15-$1.65 and full-year 2026 EPS to $5.10-$5.60 with roughly $2.5 billion of free cash flow, while nine-month operating cash flow fell 5.6% to $5,740 million. Delta's total debt and finance leases declined to $12,851 million from $14,112 million at year-end 2025, but current maturities rose to $3,324 million from $1,605 million, a near-term refinancing item to monitor. Premium and loyalty revenues (+18% each) are the clearest positive signals, indicating pricing power in the diversified revenue base. At 3M, four insider filings reflect routine equity vesting, tax withholding and option exercises at $162.12 per share by the CTO, Group President, and Chief Legal Officer, with no open-market selling evident; the implied insider sentiment is neutral. Norfolk Southern's only filing is a director's inheritance of 333.33 shares, which carries no signal. Overall the period is dominated by airline cost pressure, with fuel and labor costs offsetting strong top-line demand.

5 high priority 1 medium 6 total filings
Β· daily

US Material Events SEC 8-K Filings β€” October 09, 2026

Across the 50 filings dated October 9, 2026, the dominant themes are capital raising and balance-sheet management (ATM programs, registered directs, a $575M convertible from Vaxcyte, a $700M Atmos Energy senior note, Gray Media's refinancing and Term Loan G add-on), executive and director turnover (Avient CEO change, Quantum CFO termination, Standard Motor CFO exit, Victoria's Secret and Mitek senior departures), and corporate restructuring (MSG Sports Rangers spin-off, Evernorth/Armada business combination, Ranger Energy's $27.5M asset acquisition). Filings in the set largely lack quantified period-over-period results, so portfolio-level growth and margin trends cannot be computed reliably; the quantitative signal comes mainly from Atmos, Ashford, Alpine, Gray Media and Dentsply covenant data. Stress indicators cluster in micro-cap and SPAC names (Verde Resources auditor change with material weaknesses, Universal Safety's note financing exceeding its stated cap, Sunshine Biopharma's dilutive best-efforts deal) and in Dentsply's temporary covenant relief. Positive refinancing outcomes at Gray Media, McGraw Hill and Ares Commercial stand in contrast. The most market-moving items are the Evernorth/XRP business combination with its $6.9M unrecorded impairment exposure, Dentsply's covenant amendments, and Quantum's CFO change alongside a guidance reaffirmation.

50 high priority 50 total filings
Β· daily

Insider Trading Pulse β€” October 09, 2026

The 50 Form 4 filings dated 2026-10-09 are overwhelmingly routine insider activity: roughly 22 are director or officer equity awards, tax withholdings on vesting RSUs, or option exercises, with no clear open-market signal. The open-market sales that do stand out cluster in high-priced, momentum names (Astera Labs, Arista Networks, Marvell, Palo Alto Networks, Pacira, SailPoint), where 10b5-1 plan sales are the common mechanism and therefore carry limited information about near-term sentiment. The most notable open-market buying comes from Neogen's CEO, Mueller Water director Brian Healy, and Lion Copper & Gold director Tony Alford, all of which are small in dollar terms but are discretionary purchases. Pledge-related filings are absent from this batch, so the 'Pledge' scope element is effectively unrepresented. Several large dollar figures in the raw data (e.g., the INNSUITES and Empire State Realty entries) appear to be data-extraction artifacts rather than true transaction sizes and should be verified against the primary filings before use. Two filings (Amerant Bancorp, Security National Financial) are present in scope as insider trades but reflect minor, routine activity.

50 high priority 50 total filings
Β· daily

Dow Jones 30 Stocks SEC Filings β€” October 09, 2026

This Dow Jones 30 digest covers six SEC filings dated October 9, 2026, five newly published and one carried forward for context. Five of the six are insider or governance disclosures from 3M, Walt Disney, NVIDIA and Cisco, and the set contains no reported period-over-period financial results, so there are no revenue, margin or guidance trend comparisons to synthesize. The dominant theme is routine executive equity compensation activity at 3M, where three officers exercised or had shares withheld for taxes at the same $162.12 price, which suggests scheduled vesting rather than a directional view. Disney's EVP Woodford sold $381K of stock under a 10b5-1 plan, a modest negative signal given the plan structure. NVIDIA's director gift of 500,000 shares and Cisco's board appointment of Girish Rishi are governance events with limited near-term market impact. Overall, the filings offer little actionable alpha; the most useful takeaway is that insider activity at 3M is uniform and non-discretionary-looking, while the Disney sale is the only transaction carrying a mild bearish read.

6 high priority 6 total filings
Β· daily

US Corporate Distress Financial Stress SEC Filings β€” October 09, 2026

All five filings in this stream are distress-related, centered on US exchange listing deficiencies rather than bankruptcy filings or going-concern opinions. The common thread is Nasdaq and NYSE/NYSE American continued-listing enforcement: three companies face sub-$1 bid-price or equity-related deficiencies (Streamex, Accendra Health), and three face governance or filing-compliance failures (Better Home & Finance, IT Tech Packaging), with Alaunos already at the delisting-hearing stage. Because the enriched period-over-period, insider, capital-allocation and forward-looking fields were not populated in these filings, quantitative trend comparisons are not available; the analysis therefore rests on the explicit deadlines, notice dates and materiality ratings disclosed. The most critical development is Alaunos Therapeutics (materiality 8/10), where the October 5, 2026 delisting notice for sub-$2.5M stockholders' equity is now proceeding to a Hearings Panel with a strategic-alternatives process that carries no assured outcome. IT Tech Packaging (8/10) and Better Home & Finance (7/10) also carry near-term enforcement risk, while Streamex and Accendra have the longest cure windows (to April 2027 and roughly April 2027 respectively). Portfolio-level, the pattern is distress manifesting as exchange compliance pressure well ahead of any insolvency event.

5 high priority 5 total filings